跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,075 条关于
“DB-1311/BNT324”
全部
18,075
临床试验
589
药物
17,144
机构
251
资讯
91
去年
BNT324/DB-1311 Shows Promise in Advanced Solid Tumors: ESMO Asia 2024
5个月前
Novel B7H3 Antibody-Drug Conjugate Shows Strong Efficacy in Cervical and Ovarian Cancers
6个月前
DualityBio Achieves Phase 3 Success with Lead ADC Candidate, Advances Global Pipeline Across Multiple Cancer Types
去年
BioNTech Advances Oncology Pipeline with BNT327/PM8002 and mRNA Immunotherapies
8天前
Ris-Rez Cuts Death Risk 54% Versus Topotecan in Relapsed SCLC, First Phase III OS Win for a B7-H3 ADC
5个月前
Yingen Bio's HER2 ADC DB-1303 Receives Marketing Approval Acceptance in China for Breast Cancer Treatment
2年前
FDA Grants Fast Track Designation to BNT325/DB-1305 for Platinum-Resistant Ovarian Cancer
去年
DualityBio's HER3-Targeting ADC DB-1310 Receives FDA Fast Track Designation for EGFR-Mutant Lung Cancer
去年
HER3-Targeted ADC DB-1310 Shows Promising Results in Advanced Solid Tumors, Particularly EGFR-Mutant NSCLC
去年
OGRD Alliance Announces PLPC-DB Non-Cellular Oncology Immunotherapy Platform for Global Acquisition
第 1 页,共 10 页
上一页
下一页